Cambridge, Massachusetts
United States
47
2024-10-10
32
2025-08-19
These are the the leading inventors for applications assigned to 2seventy bio, Inc.:
2seventy bio, Inc. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
COMPOSITIONS AND METHODS FOR SITE-DIRECTED MUTAGENESIS
#2 | 2024-09-12 ✅ Patent 12,391,734 granted on 2025-08-19PD-1 HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE
#3 | 2024-08-08MODIFIED CCR POLYPEPTIDES AND USES THEREOF
#4 | 2024-06-13PCSK9 ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE
#5 | 2024-02-01DIMERIZING AGENT REGULATED IMMUNORECEPTOR COMPLEXES
#6 | 2024-01-25DIMERIZING AGENT REGULATED IMMUNORECEPTOR COMPLEXES
#7 | 2023-11-09 ✅ Patent 12,264,343 granted on 2025-04-01TCRa homing endonuclease variants
#8 | 2023-10-05BCMA CHIMERIC ANTIGEN RECEPTORS
#9 | 2023-07-06METHODS FOR MANUFACTURING VIRAL VECTORS
#10 | 2023-06-22 ✅ Patent 12,644,099 granted on 2026-06-02METHODS FOR MAKING T CELL COMPOSITIONS
#11 | 2023-06-08 ✅ Patent 12,559,742 granted on 2026-02-24DONOR REPAIR TEMPLATES MULTIPLEX GENOME EDITING
#12 | 2023-05-18 ✅ Patent 12,454,580 granted on 2025-10-28FRB ANTIBODIES
#13 | 2023-04-20T CELL RECEPTORS
#14 | 2023-02-09 ✅ Patent 12,590,136 granted on 2026-03-31ENGINEERED T CELLS
#15 | 2023-02-02DIMERIZING AGENT REGULATED IMMUNORECEPTOR COMPLEXES
#16 | 2023-02-02 ✅ Patent 12,545,746 granted on 2026-02-10ANTI-BCMA CAR ANTIBODIES, CONJUGATES, AND METHODS OF USE
#17 | 2022-11-17ADOPTIVE CELL THERAPY
#18 | 2022-10-27 ✅ Patent 11,912,746 granted on 2024-02-27PD-1 homing endonuclease variants, compositions, and methods of use
#19 | 2022-10-13 ✅ Patent 12,552,855 granted on 2026-02-17CD33 TARGETED IMMUNOTHERAPIES
#20 | 2022-10-13 ✅ Patent 12,421,315 granted on 2025-09-23CLL-1 TARGETED IMMUNOTHERAPIES
#21 | 2022-10-06CD123 TARGETED IMMUNOTHERAPIES
#22 | 2022-09-08COMPOSITIONS AND METHODS FOR TREATING CANCER
#23 | 2022-07-21CD79B CHIMERIC ANTIGEN RECEPTORS
#24 | 2022-07-14MULTIVALENT CHIMERIC ANTIGEN RECEPTOR
#25 | 2022-06-23MANUFACTURING ANTI-BCMA CAR T CELLS
#26 | 2022-06-23 ✅ Patent 11,976,116 granted on 2024-05-07Salvage chimeric antigen receptor systems
#27 | 2022-06-16 ✅ Patent 11,591,582 granted on 2023-02-28TCRα homing endonuclease variants
#28 | 2022-06-09 ✅ Patent 12,577,547 granted on 2026-03-17PDCD-1 HOMING ENDONUCLEASE VARIANTS
#29 | 2022-04-21 ✅ Patent 12,404,500 granted on 2025-09-02HOMING ENDONUCLEASE VARIANTS
#30 | 2021-08-26 ✅ Patent 12,247,084 granted on 2025-03-11Anti-BCMA CAR antibodies, conjugates, and methods of use
#31 | 2021-07-15 ✅ Patent 11,732,255 granted on 2023-08-22CBLB endonuclease variants, compositions, and methods of use
#32 | 2021-03-18 ✅ Patent 12,029,784 granted on 2024-07-09BCMA chimeric antigen receptors
#33 | 2021-02-25 ✅ Patent 11,382,965 granted on 2022-07-12BCMA chimeric antigen receptors
#34 | 2021-02-11 ✅ Patent 11,365,226 granted on 2022-06-21PD-1 homing endonuclease variants, compositions, and methods of use
#35 | 2021-02-11 ✅ Patent 11,351,236 granted on 2022-06-07BCMA chimeric antigen receptors
#36 | 2020-12-17 ✅ Patent 11,952,413 granted on 2024-04-09Dimerizing agent regulated immunoreceptor complexes comprising interleukin receptor signaling domains
#37 | 2020-12-03 ✅ Patent 11,779,654 granted on 2023-10-10PCSK9 endonuclease variants, compositions, and methods of use
#38 | 2020-10-22 ✅ Patent 11,633,463 granted on 2023-04-25BCMA chimeric antigen receptors
#39 | 2020-08-20 ✅ Patent 12,109,234 granted on 2024-10-08Anti-BCMA CAR T cell compositions
#40 | 2020-04-23 ✅ Patent 11,530,395 granted on 2022-12-20TGFBetaR2 endonuclease variants, compositions, and methods of use
#41 | 2020-04-09 ✅ Patent 11,560,547 granted on 2023-01-24Methods of making T cell compositions
#42 | 2020-03-12 ✅ Patent 12,006,369 granted on 2024-06-11BCMA chimeric antigen receptors
#43 | 2020-03-05 ✅ Patent 11,530,265 granted on 2022-12-20Multipartite signaling proteins and uses thereof
#44 | 2019-12-26 ✅ Patent 11,499,149 granted on 2022-11-15Donor repair templates multiplex genome editing
#45 | 2019-11-21 ✅ Patent 11,654,158 granted on 2023-05-23TGFBeta signal convertor
#46 | 2019-06-27 ✅ Patent 11,479,755 granted on 2022-10-25T cell compositions
#47 | 2017-02-23 ✅ Patent 12,291,722 granted on 2025-05-06Methods for manufacturing adoptive cell therapies
Also check out 2seventy bio, Inc.'s (Cambridge, United States) applicant profile with 36 patent applications submitted.
322776 ⎘